The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

splitTools: Tools for Data Splitting

Fast, lightweight toolkit for data splitting. Data sets can be partitioned into disjoint groups (e.g. into training, validation, and test) or into (repeated) k-folds for subsequent cross-validation. Besides basic splits, the package supports stratified, grouped as well as blocked splitting. Furthermore, cross-validation folds for time series data can be created. See e.g. Hastie et al. (2001) <doi:10.1007/978-0-387-84858-7> for the basic background on data partitioning and cross-validation.

Version: 1.0.1
Imports: stats
Suggests: knitr, rmarkdown, testthat (≥ 3.0.0)
Published: 2023-06-06
DOI: 10.32614/CRAN.package.splitTools
Author: Michael Mayer [aut, cre]
Maintainer: Michael Mayer <mayermichael79 at gmail.com>
BugReports: https://github.com/mayer79/splitTools/issues
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
URL: https://github.com/mayer79/splitTools
NeedsCompilation: no
Materials: README NEWS
In views: MachineLearning
CRAN checks: splitTools results

Documentation:

Reference manual: splitTools.pdf
Vignettes: Using 'splitTools'

Downloads:

Package source: splitTools_1.0.1.tar.gz
Windows binaries: r-devel: splitTools_1.0.1.zip, r-release: splitTools_1.0.1.zip, r-oldrel: splitTools_1.0.1.zip
macOS binaries: r-release (arm64): splitTools_1.0.1.tgz, r-oldrel (arm64): splitTools_1.0.1.tgz, r-release (x86_64): splitTools_1.0.1.tgz, r-oldrel (x86_64): splitTools_1.0.1.tgz
Old sources: splitTools archive

Reverse dependencies:

Reverse imports: mlexperiments
Reverse suggests: mllrnrs, mlsurvlrnrs

Linking:

Please use the canonical form https://CRAN.R-project.org/package=splitTools to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.